All articles from EyeWorld.org on the topic of cataract surgery. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
It was a successful year for the Journal of Cataract & Refractive Surgery (JCRS), the official journal of ASCRS and ESCRS, and JCRS Online Case Reports (JCRO), an online-only companion journal to JCRS. To celebrate this success, EyeWorld is featuring some of the most-viewed papers.
Patients with disabilities can experience unique challenges when in need of cataract surgery, but some ophthalmologists say the challenge for these patients begins before they ever sit in an exam chair. This vulnerable patient population can face ethical, logistical, and systemic barriers to care.
➤ New trifocal receives FDA approval ➤ Robotic system completes its first cataract surgery ➤ Interim results from first-in-human bimatoprost-IOL system ➤ Reproducible regenerative effects observed in preclinical glaucoma model ➤ Phase 3 program begins for intravitreal insert treating wet AMD, DME ➤ ASCRS news and events
EyeWorld reports on the BRiCS Summit, which took place October 3–5 in Chicago, Illinois. What the course really boils down to is increasing confidence in the premium IOL practice through education, resources, and networking connections, according to Vance Thompson, MD, chair, and William Wiley, MD, co-director.
With an increase in dry eye education and treatment options, questions can arise: Who really needs surface optimization vs. who is ready to schedule surgery now? What’s reasonable in terms of treatment? When is a patient who needed ocular surface optimization ready for surgery? Two experts shared their experiences.
➤ Accommodating lens implanted in first patient ➤ First patient dosed in Phase 2 trial investigating treatment for normal tension glaucoma ➤ Primary endpoint met in Phase 3 trial for glaucoma drop ➤ CE mark approvals ➤ Regenerative Medicine Advanced Therapy designation granted to investigational gene therapy for Stargardt disease ➤ ASCRS news and events
➤ First gene therapy treatment for macular telangiectasia type 2 performed outside of trial ➤ First patient enrolled in Phase 2b study of ocular micro implant for IOP reduction ➤ Fast Track Designation granted to Stargardt gene therapy ➤ FDA Special Protocol Assessment for non-proliferative diabetic retinopathy trial ➤ IDE granted to new glaucoma therapy system ➤ Partnership news ➤ ASCRS news and events
Manual marking, digital marking, manual and digital marking—toric IOL alignment methods continue to be an important topic. Both methods still have a place, and both have their pros and cons. Four physicians discussed their preferences.
➤ Fast Track designation granted to one-time intravitreal gene therapy for geographic atrophy ➤ FDA clears IND for Stargardt gene therapy to move forward into a Phase 1/2 clinical trial ➤ BLA submission for retinitis pigmentosa gene therapy begins ➤ First patient dosed in Phase 1/2 trial evaluating NK therapy ➤ Enrollment complete in Phase 2b trial for PCED therapy ➤ ASCRS news and events
Get the latest ophthalmology news delivered to your inbox every Friday.